Susquehanna International Group
ARNA

Susquehanna International Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Susquehanna International Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-295,200
Closed -$27.4M – 14537
2021
Q4 		$27.4M Buy
295,200
+196,800
+200% +$13M ﹤0.01% 1555
2021
Q3 		$5.86M Buy
98,400
+43,300
+79% +$2.56M ﹤0.01% 3675
2021
Q2 		$3.76M Sell
55,100
-32,700
-37% -$2.13M ﹤0.01% 4557
2021
Q1 		$6.09M Buy
87,800
+9,600
+12% +$739K ﹤0.01% 3539
2020
Q4 		$6.01M Sell
78,200
-14,800
-16% -$1.11M ﹤0.01% 3147
2020
Q3 		$6.96M Sell
93,000
-44,400
-32% -$2.96M ﹤0.01% 2659
2020
Q2 		$8.65M Buy
137,400
+66,400
+94% +$3.65M ﹤0.01% 2311
2020
Q1 		$2.98M Sell
71,000
-77,100
-52% -$3.53M ﹤0.01% 3291
2019
Q4 		$6.73M Buy
148,100
+13,700
+10% +$648K ﹤0.01% 2564
2019
Q3 		$6.15M Buy
134,400
+18,900
+16% +$1.06M ﹤0.01% 2472
2019
Q2 		$6.77M Sell
115,500
-2,700
-2% -$140K ﹤0.01% 2335
2019
Q1 		$5.3M Buy
118,200
+51,800
+78% +$2.38M ﹤0.01% 2375
2018
Q4 		$2.59M Sell
66,400
-89,800
-57% -$3.53M ﹤0.01% 3136
2018
Q3 		$7.19M Buy
156,200
+40,000
+34% +$1.62M ﹤0.01% 2262
2018
Q2 		$5.07M Sell
116,200
-140,800
-55% -$6.05M ﹤0.01% 2687
2018
Q1 		$10.2M Sell
257,000
-6,500
-2% -$253K ﹤0.01% 1752
2017
Q4 		$8.95M Sell
263,500
-57,400
-18% -$1.64M ﹤0.01% 1922
2017
Q3 		$8.18M Buy
320,900
+149,700
+87% +$3.43M ﹤0.01% 1962
2017
Q2 		$2.89M Buy
171,200
+156,120
+1,035% +$2.14M ﹤0.01% 3229
2017
Q1 		$220K Sell
15,080
-35,650
-70% -$528K ﹤0.01% 7869
2016
Q4 		$720K Buy
50,730
+5,460
+12% +$84.6K ﹤0.01% 6216
2016
Q3 		$792K Sell
45,270
-660
-1% -$10.9K ﹤0.01% 5231
2016
Q2 		$785K Buy
45,930
+1,180
+3% +$21.1K ﹤0.01% 5336
2016
Q1 		$882K Sell
44,750
-43,650
-49% -$700K ﹤0.01% 5343
2015
Q4 		$1.68M Buy
88,400
+1,840
+2% +$37.5K ﹤0.01% 4387
2015
Q3 		$1.65M Sell
86,560
-31,700
-27% -$1.08M ﹤0.01% 4647
2015
Q2 		$5.49M Sell
118,260
-45,820
-28% -$1.99M ﹤0.01% 2769
2015
Q1 		$7.17M Sell
164,080
-147,680
-47% -$6.86M ﹤0.01% 2249
2014
Q4 		$10.8M Buy
311,760
+11,470
+4% +$466K ﹤0.01% 1946
2014
Q3 		$12.6M Sell
300,290
-49,790
-14% -$2.22M ﹤0.01% 1860
2014
Q2 		$20.5M Buy
350,080
+43,540
+14% +$2.74M 0.01% 1376
2014
Q1 		$19.3M Sell
306,540
-12,240
-4% -$812K 0.01% 1305
2013
Q4 		$18.6M Buy
318,780
+44,210
+16% +$2.31M 0.01% 1416
2013
Q3 		$14.5M Buy
274,570
+22,150
+9% +$1.49M 0.01% 1505
2013
Q2 		$19.4M Buy
+252,420
New +$20.6M 0.01% 1147

Susquehanna International Group's ARNA Position: Q1 2022 in Review

Susquehanna International Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 190,490 shares — an estimated $17.7M sold.

Susquehanna International Group first reported a position in ARNA in Q2 2013 and held it in 33 quarters. The position peaked at $23.8M in Q2 2014. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Susquehanna International Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Susquehanna International Group sold 190,490 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $17.7M.
  • Susquehanna International Group first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
  • Susquehanna International Group's Arena Pharmaceuticals Inc position peaked at $23.8M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.